FDA Inspection 1105940 — Mibo Medical Group
The FDA completed an inspection of Mibo Medical Group on September 30, 2019 in Dallas, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 30, 2019
- Fiscal Year
- 2019
- Product Type
- Devices
- Project Area
- Compliance: Devices
- Location
- Dallas, TX (United States)